We & Win Diversification Co., Ltd. (4113.TWO) Stock
We & Win Diversification Co., Ltd., a company headquartered in Kaohsiung City, Taiwan, primarily focuses on the acquisition, rental, and sale of real estate properties across the island. Beyond its core property activities, the firm's operations encompass a diverse range of sectors, including investments in public infrastructure projects, the development of new towns and communities, the wholesale distribution of medical equipment, and various international trade endeavors.
Valuation
Financials & Margins
Latest News
Valuation & Return Ratios
Peer Comparison
About We & Win Diversification Co., Ltd.
We & Win Diversification Co., Ltd., a company headquartered in Kaohsiung City, Taiwan, primarily focuses on the acquisition, rental, and sale of real estate properties across the island. Beyond its core property activities, the firm's operations encompass a diverse range of sectors, including investments in public infrastructure projects, the development of new towns and communities, the wholesale distribution of medical equipment, and various international trade endeavors. Established in 1987, the entity originally traded as Oncoprobe Biotech Inc. before adopting its current designation of We & Win Diversification Co., Ltd. in 2009.
We & Win Diversification Co., Ltd. is led by CEO Yung-Yi Su, employs 35 people, headquartered in Kaohsiung City, TW, publicly traded since 2007.
over the past 52 weeks the stock has ranged between $13.90 and $26.60, and currently trades 43.6% below its 52-week high.
Official website: kh.vvvvv.com.tw